Protalix BioTherapeutics Inc (PLX)
1.76
+0.02
(+1.15%)
USD |
NYAM |
Dec 20, 16:00
1.755
0.00 (0.00%)
After-Hours: 20:00
Protalix BioTherapeutics Market Cap: 129.60M for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Accuray Inc | 185.54M |
AIM ImmunoTech Inc | 12.10M |
Perspective Therapeutics Inc | 192.62M |
Electromed Inc | 234.54M |
Armata Pharmaceuticals Inc | 70.56M |
Market Cap Related Metrics
PS Ratio | 3.027 |
Price to Book Value | 3.995 |
Price to Free Cash Flow | 19.27 |
Price | 1.76 |
Earnings Yield | -9.09% |